Subscribe to RSS
DOI: 10.1055/s-2007-1011856
© Georg Thieme Verlag, Stuttgart · New York
Effects of Calcium Hopantenate on the Release of Thyrotropin-Releasing Hormone from the Rat Adrenal Gland In Vitro
Publication History
1986
1987
Publication Date:
14 March 2008 (online)
![](https://www.thieme-connect.de/media/hmr/198710/lookinside/thumbnails/10.1055-s-2007-1011856-1.jpg)
Summary
The effects of calcium hopantenate (HOPA), a GABA agonist, on the release of thyrotropin-releasing hormone (TRH) from the rat adrenal gland were studied in vitro. The adrenal glands were incubated in medium 199 with 1.0 mg/ml of bacitracin (pH 7.4) (medium) for 20 min. The amount of TRH release into the medium was measured by radioimmunoassay.
The TRH release from the rat adrenal gland was inhibited significantly in a dose-related manner with the addition of HOPA to the medium. HOPA's effects on TRH release from the adrenal gland were blocked with the addition of bicuculline, a GABA receptor inhibitor. The elution profile of methanol-extracted rat adrenal gland TRH was identical to that for synthetic TRH.
The findings suggest that HOPA inhibits TRH release from the rat adrenal gland, and that its effects are mediated via the GABA receptor.
Key-Words
Thyrotropin-Releasing Hormone - Calcium Hopantenate - Adrenal Gland - Bicuculline